X

hypersensitivity pneumonitis

Scotland: Hope for patients with pulmonary fibrosis

The Scottish Medicines Consortium (SMC) has announced that the anti-fibrotic medicine nintedanib has been accepted for use by NHS Scotland…

This website uses cookies.